Literature DB >> 5050439

Malignant mesothelial tumors - histologic type and asbestos exposure.

D Magner, A D McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5050439

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; E I Beissner; J Gluckman; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

Review 2.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

Review 3.  Diffuse malignant mesothelioma: a review.

Authors:  W N Rom; J E Lockey
Journal:  West J Med       Date:  1982-12

4.  Malignant mesothelioma in women.

Authors:  A Dawson; A R Gibbs; F D Pooley; D M Griffiths; J Hoy
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

5.  Evidence for longer survival of patients with pleural mesothelioma without asbestos exposure.

Authors:  M R Law; F G Ward; M E Hodson; B E Heard
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

6.  Epidemiologic surveillance of mesothelioma in Canada.

Authors:  A D McDonald; J C McDonald
Journal:  Can Med Assoc J       Date:  1973-09-01       Impact factor: 8.262

7.  Histological types of malignant mesothelioma and asbestos exposure.

Authors:  W E Wright; R P Sherwin
Journal:  Br J Ind Med       Date:  1984-11

8.  Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.

Authors:  Akesh Thomas; Sajin Karakattu; Jeanette Cagle; Girendra Hoskere
Journal:  Cureus       Date:  2021-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.